KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX )

Go back to KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX )
(NASDAQ: RXRX) Delayed: 3.80 +0.33 (9.51%)
Previous Close $3.47    52 Week High
Open $3.44    52 Week Low
Day High $4.04    P/E N/A 
Day Low $3.44    EPS
Volume 38,434,749